Sarcopenia is the loss of muscle strength, mass, and function, which is often exacerbated by
chronic comorbidities including cardiovascular diseases, chronic kidney disease, and …

The definition of sarcopenia, the age-related loss of muscle mass, has evolved since the
term's inception and yet there is no consensus. Many of the identified definitions of …

Introduction: Loss of skeletal muscle mass and function (sarcopenia) is common in
individuals with obesity due to metabolic changes associated with a sedentary lifestyle …

Summary The Global Leadership Initiative on Malnutrition (GLIM) provides consensus
criteria for the diagnosis of malnutrition that can be widely applied. The GLIM approach is …

There is no consensus on the prevalence of sarcopenia or its impact on mortality in end‐
stage renal disease patients undergoing dialysis. This review aimed to summarize the …

It is well recognized that poor muscle function and poor physical performance are strong
predictors of clinically relevant adverse events in older people. Given the large number of …

Summary Background & Aims Bioelectrical impedance analysis-derived phase angle (PhA)
has been gaining attention in the clinical evaluation of nutritional status because it is thought …

Aging is associated with an increased risk of frailty, disability, and mortality. Strategies to
delay the degenerative changes associated with aging and frailty are particularly interesting …

Nicotinamide adenine dinucleotide (NAD+) is modulated by conditions of metabolic stress
and has been reported to decline with aging in preclinical models, but human data are …

Background Sarcopenia, an age-related decline in muscle mass and function, is one of the
most important health problems in elderly with a high rate of adverse outcomes. However …